Invention Grant
- Patent Title: PRKC fusions
-
Application No.: US15326359Application Date: 2015-07-15
-
Publication No.: US10370724B2Publication Date: 2019-08-06
- Inventor: Nicolas Stransky , Joseph L. Kim
- Applicant: BLUEPRINT MEDICINES CORPORATION
- Applicant Address: US MA Cambridge
- Assignee: Blueprint Medicines Corporation
- Current Assignee: Blueprint Medicines Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow Garrett & Dunner, LLP
- International Application: PCT/US2015/040560 WO 20150715
- International Announcement: WO2016/011147 WO 20160121
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/04 ; C12Q1/6886 ; C07K16/30 ; C12N15/113 ; G01N33/574
Abstract:
The invention provides PRKC gene fusions, PRKC fusion proteins, and fragments of those genes and polypeptides. The invention further provides methods of diagnosing and treating diseases or disorders associated with PRKC fusions, such as conditions mediated by aberrant PRKC expression or activity, or overexpression of PRKC.
Public/Granted literature
- US20170211148A1 PRKC FUSIONS Public/Granted day:2017-07-27
Information query
